According to the chapter Strategic Focus, all of the following are reasons why Pfizer concluded that the acquisition of Wyeth was in the best interest of stakeholders EXCEPT
A) Wyeth had been investing heavily in biotechnology and vaccines for about three decades.
B) Pfizer wanted to gain access to new products that might flow from Wyeth's biotechnology-oriented R&D investments.
C) Lipitor was a failure for Pfizer and Wyeth had the potential to contribute a top-selling drug.
D) Wyeth could contribute to Pfizer's sales revenue which was expected to decline when Lipitor came off patent.

Question

Quizplus · Accepted Answer

The chapter does not mention that Lipitor was a failure for Pfizer. In fact, Lipitor was one of Pfizer's top-selling drugs, but it was coming off patent which would lead to a decline in sales revenue. Therefore, acquiring Wyeth was seen as a way to offset this decline by gaining access to new products and potential top-selling drugs.

According to the Chapter Strategic Focus, All of the Following